Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Aug 31

PMID 27575603

Citations 36

Authors

Naureen Fatima

Syed Mohd Faisal

Swaleha Zubair

Mohd Ajmal

Sheelu Shafiq Siddiqui

Shagufta Moin

Mohammad Owais

Affiliations

Soon will be listed here.

Abstract

Background: Type 1 diabetes mellitus is a chronic inflammatory disease involving insulin producing β-cells destroyed by the conjoined action of auto reactive T-cells, inflammatory cytokines and monocytic cells. The aim of this study was to elucidate the status of pro-inflammatory cytokines and biochemical markers and possible correlation of these factors towards outcome of the disease.

Methods: The study was carried out on 29 T1D subjects and 20 healthy subjects. Plasma levels of oxidative stress markers, enzymatic and non-enzymatic antioxidants were estimated employing biochemical assays. The levels of pro-inflammatory cytokines such as by IL-1β & IL-17 in the serum were determined by ELISA, while the expression of TNF-α, IL-23 & IFN-γ was ascertained by qRT-PCR.

Results: The onset of T1D disease was accompanied with elevation in levels of Plasma malondialdehyde, protein carbonyl content and nitric oxide while plasma vitamin C, reduced glutathione and erythrocyte sulfhydryl groups were found to be significantly decreased in T1D patients as compared to healthy control subjects. Activity of antioxidant enzymes, superoxide dismutase, catalase, glutathione reductase and glutathione-s-transferase showed a significant suppression in the erythrocytes of T1D patients as compared to healthy subjects. Nevertheless, the levels of pro-inflammatory cytokines IL-1β and IL-17A were significantly augmented (***p≤.001) on one hand, while expression of T cell based cytokines IFN-γ, TNF-α and IL-23 was also up-regulated (*p≤.05) as compared to healthy human subjects.

Conclusion: The level of pro-inflammatory cytokines and specific biochemical markers in the serum of the patient can be exploited as potential markers for type 1 diabetes pathogenesis. The study suggests that level of inflammatory markers is up-regulated in T1D patients in an age dependent manner.

Citing Articles

Comparative Study of Oxidative Stress Responses in Pediatric Type 1 Diabetes and Transient Hyperglycemia.

Pinzaru A, Lupu A, Chisnoiu T, Baciu G, Baciu A, Baciu C Int J Mol Sci. 2025; 26(4).

PMID: 40004164 PMC: 11855318. DOI: 10.3390/ijms26041701.

Interleukin in Immune-Mediated Diseases: An Updated Review.

Zaroon , Aslam S, Hafsa , Mustafa U, Fatima S, Bashir H Mol Biotechnol. 2024; .

PMID: 39715931 DOI: 10.1007/s12033-024-01347-8.

Sex-specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors.

Girdhar K, Mine K, DaCosta J, Atkinson M, Ludvigsson J, Altindis E FASEB J. 2024; 38(24):e70270.

PMID: 39704278 PMC: 11660211. DOI: 10.1096/fj.202402354R.

Risk of Type 1 Diabetes Mellitus in SARS-CoV-2 Patients.

Chahal S, Raj R, Kumar R Curr Diabetes Rev. 2024; 21(5):e240524230298.

PMID: 38798206 DOI: 10.2174/0115733998290807240522045553.

S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects.

Ursino G, Lucibello G, Teixeira P, Hofler A, Veyrat-Durebex C, Odouard S Sci Adv. 2024; 10(1):eadj4686.

PMID: 38170783 PMC: 10796079. DOI: 10.1126/sciadv.adj4686.

References

Steck A, Rewers M . Genetics of type 1 diabetes. Clin Chem. 2011; 57(2):176-85. PMC: 4874193. DOI: 10.1373/clinchem.2010.148221. View

Szablewski L . Role of immune system in type 1 diabetes mellitus pathogenesis. Int Immunopharmacol. 2014; 22(1):182-91. DOI: 10.1016/j.intimp.2014.06.033. View

Yen D, Cheung J, Scheerens H, Poulet F, Mcclanahan T, McKenzie B . IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006; 116(5):1310-6. PMC: 1451201. DOI: 10.1172/JCI21404. View

Padgett L, Broniowska K, Hansen P, Corbett J, Tse H . The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis. Ann N Y Acad Sci. 2013; 1281:16-35. PMC: 3715103. DOI: 10.1111/j.1749-6632.2012.06826.x. View

Dave G, Kalia K . Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. Cell Mol Biol (Noisy-le-grand). 2007; 53(5):68-78. View

Ohkawa H, Ohishi N, Yagi K . Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8. DOI: 10.1016/0003-2697(79)90738-3. View

Kahaly G, Hansen M . Type 1 diabetes associated autoimmunity. Autoimmun Rev. 2016; 15(7):644-8. DOI: 10.1016/j.autrev.2016.02.017. View

Sunal E, Kanbak G . Age-related changes in the glutathione redox system. Cell Biochem Funct. 2002; 20(1):61-6. DOI: 10.1002/cbf.937. View

Marklund S, Marklund G . Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974; 47(3):469-74. DOI: 10.1111/j.1432-1033.1974.tb03714.x. View

10.

Ziobro A, Duchnowicz P, Mulik A, Koter-Michalak M, Broncel M . Oxidative damages in erythrocytes of patients with metabolic syndrome. Mol Cell Biochem. 2013; 378(1-2):267-73. PMC: 3634977. DOI: 10.1007/s11010-013-1617-7. View

11.

Gleisner A, Martinez L, Pino R, Rojas I, Martinez A, Asenjo S . Oxidative stress markers in plasma and urine of prepubertal patients with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2006; 19(8):995-1000. DOI: 10.1515/jpem.2006.19.8.995. View

12.

Delmastro M, Piganelli J . Oxidative stress and redox modulation potential in type 1 diabetes. Clin Dev Immunol. 2011; 2011:593863. PMC: 3102468. DOI: 10.1155/2011/593863. View

13.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008; 31 Suppl 1:S55-60. DOI: 10.2337/dc08-S055. View

14.

Iwakura Y, Ishigame H . The IL-23/IL-17 axis in inflammation. J Clin Invest. 2006; 116(5):1218-22. PMC: 1451213. DOI: 10.1172/JCI28508. View

15.

Grisham M, Johnson G, Lancaster Jr J . Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol. 1996; 268:237-46. DOI: 10.1016/s0076-6879(96)68026-4. View

16.

Benzie I, Strain J . The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem. 1996; 239(1):70-6. DOI: 10.1006/abio.1996.0292. View

17.

Hoarau E, Chandra V, Rustin P, Scharfmann R, Duvillie B . Pro-oxidant/antioxidant balance controls pancreatic β-cell differentiation through the ERK1/2 pathway. Cell Death Dis. 2014; 5:e1487. PMC: 4237262. DOI: 10.1038/cddis.2014.441. View

18.

Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani M, Larijani B . Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res. 2005; 36(4):376-81. DOI: 10.1016/j.arcmed.2005.03.007. View

19.

Shi X, Li D, Deng Q, Li Y, Sun G, Yuan X . NEFAs activate the oxidative stress-mediated NF-κB signaling pathway to induce inflammatory response in calf hepatocytes. J Steroid Biochem Mol Biol. 2014; 145:103-12. DOI: 10.1016/j.jsbmb.2014.10.014. View

20.

Levine R, Garland D, Oliver C, Amici A, Climent I, Lenz A . Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990; 186:464-78. DOI: 10.1016/0076-6879(90)86141-h. View